找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Drug Resistance in Cancer Therapy; Robert F. Ozols Book 1989 Kluwer Academic Publishers 1989 Staging.Tumor.breast cancer.calcium.cancer.ca

[复制链接]
查看: 23701|回复: 47
发表于 2025-3-21 18:00:52 | 显示全部楼层 |阅读模式
书目名称Drug Resistance in Cancer Therapy
编辑Robert F. Ozols
视频video
丛书名称Cancer Treatment and Research
图书封面Titlebook: Drug Resistance in Cancer Therapy;  Robert F. Ozols Book 1989 Kluwer Academic Publishers 1989 Staging.Tumor.breast cancer.calcium.cancer.ca
描述Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good in-depth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfor­ tunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes that aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion: first, by dividing the oncology literature into specific subdivisions such as lung can­ cer, genitourinary cancer, and pediatric oncology; second, by askin
出版日期Book 1989
关键词Staging; Tumor; breast cancer; calcium; cancer; cancer therapy; cancer treatment; cell; chemotherapy; diagnos
版次1
doihttps://doi.org/10.1007/978-1-4613-1601-5
isbn_softcover978-1-4612-8886-2
isbn_ebook978-1-4613-1601-5Series ISSN 0927-3042 Series E-ISSN 2509-8497
issn_series 0927-3042
copyrightKluwer Academic Publishers 1989
The information of publication is updating

书目名称Drug Resistance in Cancer Therapy影响因子(影响力)




书目名称Drug Resistance in Cancer Therapy影响因子(影响力)学科排名




书目名称Drug Resistance in Cancer Therapy网络公开度




书目名称Drug Resistance in Cancer Therapy网络公开度学科排名




书目名称Drug Resistance in Cancer Therapy被引频次




书目名称Drug Resistance in Cancer Therapy被引频次学科排名




书目名称Drug Resistance in Cancer Therapy年度引用




书目名称Drug Resistance in Cancer Therapy年度引用学科排名




书目名称Drug Resistance in Cancer Therapy读者反馈




书目名称Drug Resistance in Cancer Therapy读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:16:56 | 显示全部楼层
Mathematical models of drug resistance and chemotherapy effects,s the researcher to make explicit assumptions about the phenomenon he is studying and to place these within a rigorous mathematical framework. In this paper, we will describe some of the work that has been done in the specific area of drug resistance, beginning with earlier minimal models of the phe
发表于 2025-3-22 02:23:58 | 显示全部楼层
发表于 2025-3-22 05:21:40 | 显示全部楼层
发表于 2025-3-22 10:49:38 | 显示全部楼层
Anthracycline resistance,sely related anthracycline, was discovered in 1969 and also showed potent antitumor activity [2,3]. Today, daunorubicin and doxorubicin are used extensively in cancer chemotherapy, although severe side effects and development of drug resistance continue to place limits on the effectiveness of these
发表于 2025-3-22 16:37:08 | 显示全部楼层
Circumvention of drug resistance with calcium channel blockers and monoclonal antibodies,s complex. Reasons for clinical resistance include metabolic inactivation and excretion of antitumor agents by the liver, kidney, and other organs. In addition, it has been found that tumor cells can acquire resistance to anticancer drugs. It is generally accepted that drug resistance at the cellula
发表于 2025-3-22 17:14:42 | 显示全部楼层
P-glycoprotein in breast cancer,oretically optimal conditions of low tumor bulk [1], often fails to eradicate micrometastasis. Once metastasis is grossly evident, most breast cancers have intrinsic resistance to single-agent chemotherapy. The response rate of such advanced disease to doxorubicin is less than 40%; the response rate
发表于 2025-3-22 21:59:53 | 显示全部楼层
发表于 2025-3-23 04:58:04 | 显示全部楼层
Alkylating agent resistance,remain major obstacles to the successful treatment of human neoplasms. A large number of solid tumors that fail to respond to chemotherapy do so because they possess characteristics that allow them to circumvent pharmacological effects. Whether these characteristics are inherently present or are the
发表于 2025-3-23 08:01:39 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-19 01:36
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表